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bstract
bjectives:  Using smaller volumes of contrast media (CM) in CT angiography (CTA) is desirable in terms of cost reduction and prevention of
ontrast-induced nephropathy (CIN). The purpose was to evaluate the feasibility of low CM volume in CTA of the aorta.
ethods:  77 patients referred for CTA of the aorta were scanned using a standard MDCT protocol at 100 kV. A bolus of 50 ml CM (Iopromide
00 mg Iodine/ml) at a flow rate of 6 ml/s was applied (Iodine delivery rate IDR = 1.8 g/s; Iodine load 15 g) followed by a saline bolus of 40 ml
t the same flow rate. Scan delay was determined by the test bolus method. Subjective image quality was assessed and contrast enhancement was
easured at 10 anatomical levels of the aorta.
esults:  Diagnostic quality images were obtained for all patients, reaching a mean overall contrast enhancement of 324 ±  28 HU. Mean attenuation
as 350 ±  60 HU at the thoracic aorta and 315 ±  83 HU at the abdominal aorta.
onclusions:  A straightforward low volume CM protocol proved to be technically feasible and led to CTA examinations reaching diagnostic image
uality of the aorta at 100 kV. Based on these findings, the use of a relatively small CM bolus can be incorporated into routine clinical imaging.
 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Key  points
• A  relatively  small  contrast  media  bolus  leads  to
diagnostic  quality  thoracic-abdominal  CTA.
• 100  kV  settings  are  appropriate  for  CTA  of  the
aorta.
.  IntroductionComputed tomography angiography (CTA) is currently the
tandard non-invasive imaging method used for the assessment
∗ Corresponding author at: Maastricht University Medical Centre, P. Debye-
aan 25, PO Box 5800, 6202 AZ Maastricht, The Netherlands.
el.: +31 43 3876543; fax: +31 43 3877093.
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http://creativecommons.org/licenses/by-nc-nd/4.0/).f the aorta. This is mainly due to high image quality, fast
cquisition and easy post processing. Indications for CTA are
road, including preoperative evaluation, imaging of aortic
neurysm, aortic dissection or planning for endovascular pro-
edures (EVAR).
Several studies have been conducted concerning sufficient
iagnostic luminal attenuation [1–3]. According to the results
f those studies, minimal enhancement of vascular structures of
iagnostic quality varies between 250 and 350 HU. To achieve
ptimal enhancement various factors have to be considered
4]: (1) scanner- and scan protocol-related factors, such as kV,
ube current, pitch, gantry rotation, and timing of the scan
scan delay); especially in newest scan techniques such as
igh pitch scanning [5,6]. (2) Patient-related factors, such as
eight, body mass index (BMI) and cardiac output, whose
nfluence can be taken into account and compensated for in
ndividualized protocols (e.g. weight-adapted CM protocols)
7–10]; (3) CM and CM administration parameters, which can
e modified according to scan technique and patient character-
stics.
is an open access article under the CC BY-NC-ND license
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According to Bae et al. [4] the key parameters of CM
re concentration, volume, physicochemistry (e.g. viscosity or
emperature), injection duration and flow rate. Several studies
ndicate that the Iodine delivery rate (IDR = the amount of Iodine
dministered to a patient per second in gI/s) is one of the most
mportant parameters for intravascular enhancement [11–13].
In recent years, CM volume reduction has consistently been in
he center of research [14–18], with the goal to use CM more effi-
iently. Apart from faster scanning techniques, new scanner- and
specially the latest detector technologies with use of lower kV
rotocols facilitate lower CM volume. With lower kV settings,
ontrast to noise ratio (CNR) increases due to decreasing pho-
on energy which approaches the k-edge of Iodine at 33 keV [19]
esulting in higher enhancement with lower amount of Iodine.
hus a reduction in CM volume may be achieved without loss of
iagnostic image quality, which would be an important improve-
ent in view of potential contrast-induced nephropathy (CIN)
20–22].
Therefore the purpose of this study was to evaluate the fea-
ibility of a low volume CM protocol in 100 kV CTA of the
orta.
.  Materials  and  methods
.1.  Study  population
Seventy-seven consecutive patients referred for CTA of the
orta were evaluated. Indications for CTA were as follows:
reoperative evaluation (n  = 7), EVAR or open aortic surgery
ollow-up (n  = 35), aortic aneurysm (n  = 21), clinical suspicion
f bleeding (n  = 3), aortic dissection (n  = 1), ischemia (n  = 5),
earch for source of pulmonary embolism (n  = 2), follow-up of
ung tumor (n  = 1) and no specified indication (n  = 2).
For statistical purposes, patients were divided into 3 groups
ccording to the aorta protocol they were referred for: thoracic
orta (group 1), abdominal aorta (group 2) or combined thoracic-
bdominal aorta (group 3).
A waiver of informed consent was given by the local ethical
ommittee (METC 14-4-050).
.2.  CM  administration  protocol
In order to assess scan start delay, all patients received a
est bolus (10 ml Iopromide 300 – Ultravist, Bayer Healthcare,
erlin, Germany – at 6 ml/s, followed by 40 ml saline flush at the
ame flow rate) through an 18 G i.v. needle (Vasofix®, BBraun,
elsung, Germany) placed in an antecubital vein.
In order to assess time to peak (TTP), a region of interest
ROI) was placed either at the level of the aortic arch for thoracic
r combined thoracic-abdominal CTAs, or at the level of L1–L2
bdominal aorta CTAs, using a dedicated software tool (DynEva,
iemens Medical, Forchheim, Germany). Scan start delay was
alculated from test bolus delay (10 s) + measured TTP + 4 s.
uring the latter 4 s breathing instructions were given to the
atient and the scan table was moved to its starting position.
The main bolus consisted of 50 ml CM followed by a 40 ml
aline chaser, both injected at a flow rate of 6 ml/s (IDR 1.8 g/s,
o
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otal Iodine load TIL = 15 g). CM was prewarmed to body tem-
erature (37 ◦C) prior to injection.
All injection parameters were closely monitored by a ded-
cated software tool (CertegraTM Informatics Platform, Bayer
ealthcare, Berlin, Germany).
.3.  Scan  protocol
Patients were scanned on a multidetector-row CT (MDCT)
2nd generation dual source scanner, SOMATOM Defini-
ion Flash, Siemens, Forchheim, Germany). Scan parameters
ere as follows: 2 ×  128 ×  0.6 mm (using z-flying focal spot
echniques), pitch value 0.9, 100 kV, quality ref. mAs 120
+CareDose4D), rot. time 0.33 s, 1.0/0.8 mm slice reconstruc-
ion and soft tissue filter (B30f).
.4.  Quantitative  and  qualitative  analysis
Measurements were carried out at 10 different anatomic
ocations using a dedicated software tool (syngo.via, Siemens,
orchheim, Germany) – 5 thoracic and 5 abdominal: T1 ascend-
ng aorta; T2 aortic arch; T3 transition aortic arch – descending
orta; T4 halfway T3–T5; T5 aorta at thoracic spine level Th12;
1 aorta at lumbar spine level L1; A2 halfway A1–A3; A3 aor-
ic bifurcation; A4 right common iliac artery above bifurcation;
5 right common femoral artery (see Fig. 1). At all anatomic
ocations a circular ROI was manually placed in the lumen of
he aorta, carefully avoiding calcifications (Fig. 1). Mean atten-
ation [HU] and standard deviation (SD) (indicator of image
oise) were recorded as well as contrast to noise ratio (CNR).
Overall image quality was assessed by an experienced radi-
logist (10 years of experience) for every patient on a five-point
cale [17]: grade 1 – bad, no diagnosis possible; grade 2 – poor,
ignificantly reduced diagnostic confidence; grade 3 – moderate,
ufficient image quality; grade 4 – good; and grade 5 – excellent.
.5.  Statistical  analysis
All data were processed via IBM SPSS Statistics ver. 20
SPSS Inc., Chicago, IL, USA). Body weight, length and age
ere tested for distribution among groups using a one-way
NOVA. The same test was used in order to compare atten-
ation and standard deviations between groups. All values are
xpressed as mean ±  SD or as a percentage with the absolute
alue in brackets. Significance was determined to have been
eached at p-value <0.05.
.  Results
Seven patients were excluded in the course of the study: one
ue to incorrect scan delay timing, six due to non-adherence to
he CM injection protocol – the condition of the venous system
f five patients meant that flow rates had to be decreased, and
ne patient had very low cardiac output with poor test bolus
ttenuation, leading to an increase in volume of the main CM
olus to 90 ml. Thus the final dataset consisted of 70 patients
ho underwent CTA of the aorta.
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No significant difference was found within the age, weight or
ength distribution between groups. For detailed patient infor-ation, see Table 1.
Using one-way ANOVA no significant difference in attenu-
tion was found between groups. The overall mean attenuation
t
m
i
able 1
aseline patients’ characteristics, (significant p-value <0.05).
Overall Group 1
(thoracic)
umber of examinations 70 5 
ale 90% (63) 80% (4) 
ge [years] 67.8 ± 10.9
(range 34–85)
68.6 ± 7.3
(range 60–77)
eight [kg] 82.4 ± 14.5
(range
60–159)
79.8 ± 6.7
(range 69–86)
ength [cm] 175.2 ± 6.9
(range
160–195)
175.8 ± 3.6
(range
172–180)
elay [s] 21.8 ± 4.1
(range 7–30)
20.4 ± 1.7
(range 18–22)
can time [s] 5.4 ± 1.1
(range
2.4–8.1)
3.2 ± 0.8
(range
2.4–4.2)
* Significant at <0.05.f ROIs placement.
as 324 ±  28 HU. The highest attenuation was reached in the
egion of the aortic arch and the thoracic descending aorta (T3),
he lowest intravascular enhancement was obtained in the com-
on femoral artery (A5). For detailed information on attenuation
n different anatomic regions and groups, see Table 2.
Group 2
(abdominal)
Group 3
(entire aorta)
p-value*
(ANOVA)
20 45 –
95% (19) 89% (40) –
71.9 ± 10.1
(range 48–84)
66.0 ± 11.2
(range 34–85)
0.130
87.4 ± 20.7
(range
62–159)
80.5 ± 11.1
(range
60–108)
0.198
174.8 ± 7.4
(range
162–195)
175.3 ± 7.0
(range
160–190)
0.945
24.8 ± 3.5
(range 18–30)
20.7 ± 3.9
(range 7–30)
–
4.3 ± 0.3
(range
3.6–5.0)
6.1 ± 0.5
(range
5.3–8.1)
–
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Table 2
Measured mean attenuations in HU [mean ± SD (range)], (significant p-value <0.05).
Anatomic area Total number of
examinations
Overall mean
attenuation
Group 1
(thoracic)
Group 2
(abdominal)
Group 3
(entire aorta)
p-value*
(ANOVA)
T1 (ascending aorta) 50 327 ± 68
(178–468)
379 ± 35
(326–422)
– 321 ± 69
(178–468)
0.069
T2 (aortic arch) 50 349 ± 60
(232–485)
377 ± 18
(356–399)
– 346 ± 62
(232–485)
0.279
T3 (arch – desc. aorta) 50 367 ± 63
(250–527)
394 ± 16
(365–403)
– 364 ± 66
(250–527)
0.322
T4 (½ T3–T5) 50 346 ± 66
(212–504)
361 ± 16
(339–380)
– 344 ± 70
(212–504)
0.589
T5 (Th12 level) 50 338 ± 70
(218–514)
374 ± 21
(353–408)
– 334 ± 72
(218–514)
0.226
A1 (L1 level) 65 321 ± 74
(155–580)
– 298 ± 84
(155–580)
332 ± 68
(217–471)
0.095
A2 (½ A1–A3) 64 315 ± 83
(98–590)
– 321 ± 94
(150–590)
312 ± 79
(98–489)
0.703
A3 (aortic bifurcation) 64 309 ± 87
(78–610)
– 316 ± 97
(147–610)
306 ± 83
(78–452)
0.685
A4 (RCI artery) 64 283 ± 89
(75–566)
– 297 ± 94
(106–566)
277 ± 86
(75–420)
0.421
A5 (RCF artery) 65 275 ± 102
(43–564)
– 300 ± 102
(99–564)
264 ± 101
(43–437)
0.192
Mean value for group – 324 ± 28 377 ± 24 306 ± 32 320 ± 28 –
F
i
2
a
t
i
e
C
s* Significant at <0.05.
The attenuation values for each anatomic region are shown in
ig. 2, and the same results for each scan protocol can be found
n Fig. 3.
SD of measurements are presented in Table 3. Mean SD was8 HU. Overall SD range was 11–75 HU, with lowest SD at
ortic arch (T2) and highest SD at half way between L1 and aor-
ic bifurcation (A2). Except for the A4 region (right common
w
(
g
Fig. 2. Attenuation [HU] at difliac artery above bifurcation), there was no significant differ-
nce among various protocols. Mean CNR was 15 (SD ±  3).
omparison of CNR and SNR can be found in Fig. 4. Pear-
on correlation of CNR to BMI did show a decrease of CNR
ith increasing BMI, both in thoracic and abdominal region
Fig. 5). The median image quality as rated by the radiologist was
rade 4.
ferent anatomic regions.
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Fig. 3. Attenuation in different anatomic regions and aorta protocols.
Table 3
Measured mean SD in HU [mean ± SD (range)], (significant p-value <0.05).
Anatomic area Total number of
examinations
Overall mean
SD
Group 1
(thoracic)
Group 2
(abdominal)
Group 3
(entire aorta)
p-value*
(ANOVA)
T1 (ascending aorta) 50 22 ± 5
(15–35)
24 ± 5
(17–31)
– 22 ± 4
(15–35)
0.440
T2 (aortic arch) 50 20 ± 6
(11–34)
19 ± 4
(15–24)
– 21 ± 6
(11–34)
0.568
T3 (arch – desc. aorta) 50 22 ± 6
(12–36)
18 ± 7
(12–26)
– 22 ± 6
(12–36)
0.317
T4 (½ T3–T5) 50 28 ± 6
(19–48)
31 ± 7
(25–42)
– 28 ± 6
(19–48)
0.316
T5 (Th12 level) 50 31 ± 9
(15–51)
30 ± 12
(18–48)
– 32 ± 8
(15–51)
0.613
A1 (L1 level) 65 36 ± 8
(17–57)
– 37 ± 10
(25–57)
35 ± 7
(17–53)
0.156
A2 (½ A1–A3) 64 35 ± 10
(22–75)
– 38 ± 13
(23–75)
34 ± 8
(22–58)
0.276
A3 (aortic bifurcation) 64 33 ± 9
(18–55)
– 34 ± 9
(21–55)
33 ± 8
(18–54)
0.767
A4 (RCI artery) 64 31 ± 8
(14–54)
– 33 ± 9
(17–54)
29 ± 8
(14–47)
*0.009
A5 (RCF artery) 65 21 ± 4 – 21 ± 4 21 ± 4 0.850
4
f
9
c
t
e
C
b
h
5
p
c(13–31)
* Significant at <0.05.
.  Discussion
Our results show that the use of low volume CM is feasible
or aortic CTA. Compared to our standard CM protocol (volume
6 ml), a reduction of 52% was achieved with the new proto-
ol. However, a combination of 100 kV with optimal scan delay
iming is necessary to facilitate this injection protocol.
The reduction of CM volume in CTA is widely asserted in lit-
rature. Most of the studies have been performed on pulmonary
t
a
s(13–30) (14–31)
TA, usually associated with a reduction of tube voltage to
etween 110 and 80 kV [15,16,23–25]. However, aortic CTA
as also been the center of research: Diehm et al. [14] used
0 ml of CM in the evaluation of aortoiliac aneurysm and com-
ared it to their standard protocol using 100 ml CM (Iodine
oncentration 320/350 mgI/ml, flow rate 3.5 ml/s). In contrast
o our study, CTA was only performed for the abdominal aorta,
nd bolus tracking technique was used with ROI placed at the
uprarenal aorta with a scan delay of 6 s after reaching 200 HU
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eFig. 4. SNR and CNR a
rigger point. The results revealed no significant difference in
ttenuation levels between groups, despite the use of various
M.
Nijhof et al. [17] compared a standard uniphasic injection
rotocol of 100 ml CM (Ioversol 350) to a multiphasic injection
rotocol, resulting in a decrease of CM volume to 89 ml in a
20 kV protocol for scanning the abdominal aorta. The multipha-
ic protocol was established using an exponentially decelerating
ate with a decay of 0.01 ml/s, according to outcomes of previ-
us investigations by Bae et al. [26]. Results were quantitatively
a
u
Fig. 5. Correlation of rent anatomic regions.
nd qualitatively comparable but resulted only in 11% reduction
n CM volume.
The same authors [18] compared their multiphasic injec-
ion protocol mentioned in a previous article [17], to a
rotocol with a 10 ml test bolus followed by a main bolus
f 40 ml (Ioversol 350) in 30 patients (15 patients per
roup). They did not find any statistically significant differ-
nce between attenuations, but it must be noted that only the
bdominal aorta was evaluated, and a 120 kV protocol was
sed.
CNR and BMI.
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In our study, a 100 kV protocol was used which facilitates
igher contrast enhancement due to the contrast to noise ratio
CNR) increase described earlier. Lowering kV thus allows a
eduction in CM volume. As was shown in our study, this reduc-
ion is functional not only for abdominal or thoracic CTA, but
lso in combined thoracic-abdominal protocols. It is important
o mention, however, that a relatively low volume bolus must
e exactly timed. The chosen timing in our study was fea-
ible, but we did experience some decrease of enhancement
n peripheral vessels in some patients undergoing combined
horacic-abdominal CTA. This could be due to the fact that
 fixed bolus was used, which did not account for individual
atient differences (e.g. body weight), and which furthermore
id not account for longer scan time necessary in thoracic-
bdominal examinations in comparison to just thoracic or just
bdominal scanning. Future research should incorporate these
ndings in individualized protocols.
Future developments in scanner technique – especially in
etector technology – might facilitate the use of even lower kV
ettings in an even broader range of patients, which may lead
o further increased contrast enhancement using the same bolus.
lthough 70 kV and 80 kV were possible at the used scanner
he necessary tube current to have sufficient low image noise is
ot always achievable in all patients, thus lowering kV increases
mage noise if tube current cannot be adjusted accordingly. Thus
he decision was made to use only a 100 kV protocol. This makes
he results applicable to a broad range of scanners and not only
o the newest high-end machines. Furthermore iterative recon-
truction allows reducing image noise also facilitating the use of
ower kV settings in future protocols and in scanners which are
ot capable of higher tube current settings as lower kV settings.
.1.  Limitations
This study has several limitations that should be addressed.
t is a single center study performed on a limited number of
atients, especially as far as the thoracic aorta protocol is con-
erned. In addition, only one scan acquisition technique (spiral,
tandard acquisition pitch) was used. More advanced techniques
uch as high pitch scanning might not be suitable for reduced
M volume, due to the fast image acquisition outrunning the
olus.
.2.  Possibilities
Using low volume CM is beneficial in terms of CIN preven-
ion, especially in critically ill patients and patients with known
mpaired renal function. Furthermore, efficient use of CM in
ombination with lower kV settings could decrease scanning
osts..  Conclusion
The use of a relatively low volume of CM is feasible and
iagnostic image quality in 100 kV CTA of the aorta can be
[ of Radiology Open 2 (2015) 58–65
eached. Compared to a standard injection protocol reduction of
ore than 50% is possible.
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